Dual cytokine targeting shows promise for pancreatic cancer
By John Fox
Tuesday, March 18, 2014
HONG KONG – A biological extract that targets two proinflammatory protein pathways is showing promise against pancreatic cancer and may have potential for the management of several other malignancies, researchers said. The fourth most common cause of cancer-related deaths in the U.S. and 12th worldwide, pancreatic cancer has a poor prognosis, with almost equal rates of incidence and mortality emphasizing the need for new targeted approaches for better management. In China, pancreatic cancer is the sixth leading cause of death from malignancy, with an overall five-year survival rate of just 1 percent to 3 percent.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.